Related Experiment Videos
Simple and practical parameters for differentiation between destruction-induced thyrotoxicosis and Graves'
Yukiko Izumi1, Yoh Hidaka, Hisato Tada
1Department of Laboratory Medicine, Osaka University Graduate School of Medicine, Suita, Japan. yizumi@labo.med.osaka-u.ac.jp
Clinical Endocrinology
|July 9, 2002
Summary
Simple blood tests, including the eosinophil to monocyte (Eo/Mo) ratio and FT3/FT4 ratio, can effectively differentiate Graves' thyrotoxicosis from destruction-induced thyrotoxicosis, potentially replacing radioactive iodine uptake tests.
Area of Science:
- Endocrinology and Metabolism
- Thyroid Disorders
- Clinical Diagnostics
Background:
- Differentiating between Graves' thyrotoxicosis and destruction-induced thyrotoxicosis is crucial for appropriate therapeutic selection.
- Traditional diagnostic methods, such as radioactive iodine uptake (RAIU) tests, can be invasive or unavailable.
- There is a need for simple, non-invasive parameters to distinguish these conditions.
Purpose of the Study:
- To identify simple and practical laboratory parameters for differentiating destruction-induced thyrotoxicosis from Graves' thyrotoxicosis.
- To evaluate the efficacy of these parameters compared to anti-TSH receptor antibodies (TBII) and RAIU tests.
Main Methods:
- Serum free T3 (FT3) and free T4 (FT4) levels were measured.
- Peripheral leukocyte differential counts, specifically eosinophils and monocytes, were analyzed.
- Calculated ratios included eosinophil to monocyte (Eo/Mo) ratio, FT3/FT4 ratio, and a combined Eo/Mo.FT3 index.
Main Results:
- The Eo/Mo ratio, FT3/FT4 ratio, and Eo/Mo.FT3 index were significantly higher in Graves' disease compared to painless and subacute thyroiditis.
- Specific thresholds (Eo/Mo < 0.2 and/or Eo/Mo.FT3 < 4.5) effectively identified destruction-induced thyrotoxicosis.
- These parameters demonstrated comparable diagnostic utility to TBII measurements.
Conclusions:
- The Eo/Mo ratio, FT3/FT4 ratio, and Eo/Mo.FT3 are simple, practical, and effective tools for differentiating thyrotoxicosis types.
- These laboratory markers can potentially obviate the need for RAIU testing in the differential diagnosis of thyrotoxicosis.
- The findings support the use of these ratios as valuable diagnostic aids in clinical practice.